恒指跌幅曾扩至逾900点 港交所/舜宇/美团/银娱/药明生物挫逾4%-7%
美国最新就业数据及耐用品订单远胜预期，末季GDP略上修续增4.1%，但全年确认萎缩3.5%为74年来最伤，成屋销售指数按月意外转降2.8%，加上美债孳息率继续上升，其中十年期债息去年中以来首次触及1.6%，重磅科网股仍有沽压及蓝筹股投资者趁高获利，美股昨晚在各类主要行业无一幸免下全面急挫1.8%-3.5%，纳指最伤，道指及标普由曾吐2.1%及2.8%，收窄至仅吐近1.8%及2.5%。亚太区主要股市今早全面下挫，澳洲、台湾、日本及南韩股市急吐2%-2.9%，其中日经曾急吐近950点，半日收挫722点或2.4%；但泰国及假後复市菲股逆市微升。
本港1月出口额及进口额按年升幅进一步扩至44%(前值升11.7%)及37.7%(前值升14.1%)，远胜市场预期分别升30.5%及28.8%，且分别升三个月及五个月。期内，有形贸易逆差按月再度收窄至252亿元，低於去年12月逆差457亿元及市场预期逆差445亿元。不过，恒指继昨天由最多急弹734点或近2.5%挑战10天线高见30,453无以为继，收市仅弹1.2%後，今早在港交所(00388.HK)、中移动(00941.HK)、腾讯(00700.HK)及美团(03690.HK)低开逾2%-5.5%拖累，低开662点或2.2%报29,412，跌幅随即扩至927点，低见29,147守稳本月初低位，跌幅曾收窄，回升至29,579，现造29,356，回吐717点或2.4%，成交额1,310亿元。
蓝筹股普遍跌逾1%-3%，其中重磅股腾讯低见665元守稳50天线，现造670元，跌3.1%；药明生物(02269.HK)低见95.9元创个半月低，现造96.3元，挫7.6%为最伤蓝筹。
昨午公布去年仅盈转蚀39.73亿元胜预期的银娱(00027.HK)绩後大行目标价介乎61.5-88元，花旗及里昂最进取，汇丰及瑞银最保守。该股由纪录高位连吐三天，今早失守10天线(70.74元)，最低见68.05元，现造69.6元，续挫6%为表现第二差蓝筹。金沙(01928.HK)低见35.8元，现造36.2元(刚为10天线)，跌逾4%。
港交所及美团曾失50天线(479.5元347.4元)，最低见468元及344元，现造479.2元及348.4元，下挫4.2%及5.9%，前者由纪录高位五连跌。
苹果股价四连跌，昨晚更挫逾3.5%，舜宇(02382.HK)跌破50天线(196元)，最低见190元，现造194.2元，挫5.1%。小米(01810.HK)跌4.8%曾报25.55元，创逾两个半月低。阿里(09988.HK)及百威亚太(01876.HK)也挫逾4%分别低见230.8元及23.95元，股价均失守牛熊线(238元及24.2元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
